VenoStent raises $2.3 million in seed funding

VenoStent, an advanced materials company that launched in Nashville before relocating to Houston to participate in the JLabs @ TMC facility, has announced that it has secured $2.3 million in seed funding.

The company leverages its unique polymer engineering technology to develop bioresorbable slip-on polymer wraps, called SelfWrap. The product is aimed at eliminating vascular surgery failures, at first targeting vascular access surgery required to initiate hemodialysis treatment for end-stage renal disease (ESRD) patients.

We last spotlighted the company in this article last June. Click here to read the recent update on the funding success.

Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to Include the name and contact information (phone and email) for follow-up.